Marc D. Kozin - Aug 10, 2021 Form 4 Insider Report for Dicerna Pharmaceuticals Inc (DRNA)

Role
Director
Signature
/s/ Douglas W. Pagan, attorney-in-fact
Stock symbol
DRNA
Transactions as of
Aug 10, 2021
Transactions value $
$70,986
Form type
4
Date filed
8/10/2021, 06:44 PM
Previous filing
Jun 11, 2021
Next filing
Sep 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRNA Common Stock Purchase $71K +3K +90.01% $23.66 6.33K Aug 10, 2021 Direct F1
holding DRNA Common Stock 5K Aug 10, 2021 By Marc D. Kozin Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $23.455 to $23.840, inclusive. The Reporting Person undertakes to provide to Dicerna Pharmaceuticals, Inc., any security holder of Dicerna Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.